Phase 3 Cardiomyopathy Trial, Recruiting NCT07223242 Sponsor: University of Texas Southwestern Medical Center Condition: Cardiomyopathy
Back to Cardiomyopathy

Phase 3 Cardiomyopathy Trial, Recruiting

NCT07223242
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People whose heart is pumping at a normal or preserved rate (a measure called LVEF of 50% or higher)
  • People who have been diagnosed with a type of heart failure called HFpEF — meaning they were admitted to hospital for heart failure in the past 12 months, or have a specific blood marker (NT-proBNP) above a certain level — or people considered at risk of HFpEF because they have more than 2 risk factors such as diabetes, high blood pressure, obesity, or low physical activity
  • People who score below 10 on a physical performance test (SPPB), or whose exercise capacity falls below a certain threshold on a breathing and fitness test
  • People with a BMI of 28 or above (this applies specifically for entry into the second phase of the trial)
  • People who are able to use a mobile phone and a mobile app

Who may not be able to join:

  • People who were hospitalised in the month before their first study visit
  • People with a history of falling repeatedly
  • People with significantly reduced kidney function (eGFR below 20 ml/min/1.73m²)
  • People whose heart failure medications were actively changed in the two weeks before their first study visit
  • People who are unable to take part in exercise training
  • People who are unable to complete a cardiopulmonary exercise test (a supervised test measuring how the heart and lungs respond to physical effort)
  • People with severe disease affecting the valves on the left side of the heart
  • People with advanced lung disease who require ongoing oxygen therapy
  • People who had major surgery within 3 months before screening, or who have major planned surgery scheduled during the study period
  • People whose body weight has changed by more than 5% in the 30 days before their first study visit
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
18 February 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peak Exercise Oxygen Uptake (VO2peak); Short Physical Performance Battery (SPPB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov